Trial intelligence / Profile preview

Adalimumab with Topical Calcipotriol/Betamethasone in Psoriasis

NCT00574249Phase 3Completed

Sponsor
Abbott Laboratories
Start
Nov 2007
Primary completion
Oct 2008
Modality
Monoclonal Antibodies
Countries
15
01

Overview

A Phase 3 trial of adalimumab in psoriasis, sponsored by Abbott Laboratories. Started Nov 2007; status: completed.

02

Drugs

03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT00574249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00574249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call